Stock Analysis
Waters Corporation (WAT) Stock Analysis
Waters Corporation (WAT) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Waters Corporation (WAT) currently has an AIQ Score of 57/100, indicating a neutral setup. Momentum is the strongest factor at 90/100. Value is the weakest current factor at 32/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
WAT at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $462.72 |
| AIQ Score | 57/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Buy |
| Market Cap | $30.35B |
| P/E Ratio (TTM) | 100.96 |
| Forward P/E | — |
| EPS (quarter ended 2026-07-04) | -$1.39 |
| Revenue (quarter ended 2026-07-04) | $1.65B |
| Dividend Yield (TTM) | 0.00% |
| Beta | 1.18 |
| Volume | 1.34M |
| 52-week range | $282.77-$482.28 |
| RSI 14 | 77.94 |
| 50-Day SMA | $429.02 |
| 200-Day SMA | $369.17 |
| Analyst Price Target | $433.90 |
| Next Earnings | Nov 3, 2026 |
WATWaters Corporation
Healthcare / Medical - Diagnostics & Research
Low Priority
Above Peers
Latest quote
- Momentum90
- Value32
- Quality50
- Risk resilience66
- Sentiment—
WAT Stock Analysis Summary
Waters Corporation (WAT) currently has an AIQ Score of 57/100, indicating a neutral setup. Momentum is the strongest factor at 90/100. Value is the weakest current factor at 32/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, WAT has AIQ Score of 57/100 with Momentum base of 90/100 and fading Value at 32/100. Wait for component alignment before adding exposure.
Momentum (90/100) leads while Value (32/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · -3.61% stock move · WAT classified in Medical - Diagnostics & Research.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is WAT Bullish or Bearish Right Now?
WAT currently has a neutral overall setup. Momentum is the strongest factor at 90/100, while Value is weakest at 32/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Momentum is constructive at 90/100.
- - Risk Resilience is supportive at 66/100.
- - Price is +11.90% above its 50-day SMA.
- - Technical consensus has more buy votes than sell votes (38 vs 6).
- - Value is the current constraint at 32/100.
- - Analyst target implies -6.23% downside from the latest quote.
Current Consensus
WAT's Technical Analysis Consensus is currently Strong Buy, with 38 buy, 1 neutral, and 6 sell votes. WAT's 14-day RSI is 77.94, which places the stock in an overbought momentum range. WAT's beta is 1.18, indicating market sensitivity broadly in line with the market.
What Changed in WAT?
The largest recent change in WAT is Momentum moving up by 9.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.
What Would Change the WAT Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
WAT Decision Framework
Public evidence layers, setup checks, and risk context for Waters Corporation.
Waters Corporation (WAT) Stock Analysis
Waters Corporation has an AIQ Score of 57/100 in a Neutral regime. Momentum is strongest at 90/100. Beta is 1.15, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | WAT is in a Neutral AIQ regime with score 57/100. |
| Signal Conflict | The primary conflict is that momentum leads at 90/100 while value lags at 32/100. |
| Factor Evidence | Momentum 90/100 · Value 32/100 · Quality 50/100 · Risk 66/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Momentum is the strongest factor at 90/100.
Momentum is 90/100 and RSI (14) is 77.9.
WAT is in a Neutral regime at 57/100.
Risk factor is 66/100 with beta 1.15 and annual volatility 35.26%.
Current conflict: momentum leads at 90/100 while value lags at 32/100.
WAT Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
WAT Fundamentals
WAT valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
WAT Technical Analysis
WAT technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
WAT Stock Catalysts
Track WAT earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
WAT Dividend Analysis
WAT dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
WAT Financial Data
WAT revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
WAT Risk Analysis
WAT volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
WAT Stock News
WAT stock news, market tone, recent headlines, and catalyst context.
WAT vs Medical Devices Peers
Current peer cohort: WAT · XRAY · ZBH · ABT · ALGN. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| WAT Current stock | 57/100 | 32/100 | 90/100 | 66/100 | 1.02 | 35.26% | Current |
| XRAY Dentsply Sirona | 51/100 | 73/100 | 53/100 | 52/100 | -0.45 | 47.92% | WAT vs XRAY |
| ZBH Zimmer Biomet | 65/100 | 66/100 | 80/100 | 55/100 | -0.02 | 32.74% | WAT vs ZBH |
| ABT Abbott Laboratories | 59/100 | 51/100 | 74/100 | 57/100 | -0.65 | 27.34% | WAT vs ABT |
| ALGN Align Technology | 67/100 | 62/100 | 76/100 | 57/100 | 0.49 | 39.27% | WAT vs ALGN |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Oct 29, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts4 recent quarterly periods are available for review.
Checked Oct 31, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jul 4, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching WAT
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for WAT
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
WAT Stock FAQ
What is WAT stock price today?
Waters Corporation's current stock price is $462.72. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is WAT bullish or bearish right now?
WAT's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is WAT's market cap?
WAT's market cap is $30.35B based on the latest completed market-close snapshot from Oct 30, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is WAT's current P/E ratio?
WAT's current P/E ratio is 100.96 based on the latest completed market-close snapshot from Oct 30, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is WAT's RSI?
WAT's 14-day RSI is 77.94 based on the latest completed market-close snapshot from Oct 30, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is WAT above its 50-day and 200-day moving averages?
WAT is 11.90% from its 50-day SMA and 30.04% from its 200-day SMA based on the latest completed market-close snapshot from Oct 30, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is WAT's next earnings date?
WAT's next earnings date is currently listed as Nov 3, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does WAT pay a dividend?
WAT's dividend yield is 0.00% based on the latest completed market-close snapshot from Oct 30, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.